ampio pharmaceuticals stock target price

The brokerage issued a sell rating on the stock. 3 rows Highest Target Price Lowest Target Price Average Target Price Current Price Upside.

Ampe Stock Price And Chart Amex Ampe Tradingview

Earnings data Q3.

. AMPE stock quote history news and other vital information to help you with your stock trading and investing. Alliance Global Partners analystJames Molloyinitiated coverage on Ampio Pharmaceuticals with a Buy rating and announced a 450 price target which is well above current levels. Stock quote stock chart quotes analysis advice financials and news for share AMPIO PHARMACEUTICALS INC.

Alliance Global Partners analyst James Molloy initiated coverage of Ampio with a Buy rating and 450 price target. Amount of Analyst Coverage Ampio Pharmaceuticals has only been the subject of 1 research reports in the past 90 days. Set Alert Options Streaming Charts.

AMPE is 05546 last updated Wed Dec 29 2021 205957 GMT0000 Coordinated Universal Time. Is a biopharmaceutical company focused on the development and advancement of immunology-based therapies for prevalent inflammatory conditions. Looking to buy Ampio Pharmaceuticals stock.

In the context of Pharmaceutical Products stocks Ampio Pharmaceuticals Incs average analyst. List of events that could affect this stock. According to analysts consensus price target of 450 Ampio Pharmaceuticals has a forecasted upside of 9092 from its current price of 045.

View todays AMPE stock price trade commission-free and discuss AMPE stock updates with the investor community. The company is developing Ampion to treat severe osteoarthritis of the knee or OAK 1918. Analyst ratings historical stock prices earnings estimates actuals.

The best long-term short-term Ampio Pharmaceuticals share. Ampio Pharmaceuticals started at buy with 450 stock price target at Alliance Global Partners. According to 1 Wall Street analyst that have issued a 1 year AMPE price target the average AMPE price target is 450 with the highest AMPE stock price forecast at 450 and the lowest AMPE stock price forecast at 450.

What analysts think AMPE will be worth. 6 hours agoOppenheimer lowered their target price on BioCryst Pharmaceuticals from 2000 to 1600 and set an outperform rating on the stock in. Stock Price Forecast The 2 analysts offering 12-month price forecasts for Ampio Pharmaceuticals Inc have a median target of 425 with a high estimate of 450 and a low estimate of 400.

Ampio Pharmaceuticals started at buy with 450 stock price target at Alliance Global Partners. According to the issued ratings of 1 analysts in the last year the average twelve-month price target for Ampio Pharmaceuticals is 450 with a high price target of 450 and a low price target of 450. The company is set.

The most common way Ampio Pharmaceuticals analysts use to provide recommendation to the public is financial statements. That average ranking earns Ampio Pharmaceuticals Inc an Analyst Rating of 73 which is better than 73 of stocks based on data compiled by InvestorsObserver. What is AMPEs Price Target.

Last Price 041 AMEX Closing Price as of 800PM ET 41122. Cash and Cash Equivalents of 34 Million Expected to Fund Current Operations into 2H 2023. Find the latest Ampio Pharmaceuticals Inc.

Ampio initiated with a Buy at Alliance Global Partners. AMPE a biopharmaceutical company focused on the advancement of. The average price target is 4 which means analysts expect the stock to rise by 83023 over the next twelve months.

Ampio has traded between 39 cents and 2 over a 52-week period. Ampio Pharmaceuticals Stock Forecast AMPE stock price prediction. Company to host Conference Call Tuesday March 29 2022 at 430pm EDT ENGLEWOOD Colo March 29 2022 PRNewswire -- Ampio Pharmaceuticals Inc.

AMPE Price Action. Price target in 14 days. The stock was up 537 at 66 cents at time of.

The stock price for. AMPE updated stock price target summary. The current projected Ampio Pharmaceuticals target price consensus is 40 with 1 analyst opinions.

Ampio Pharmaceuticals Inc AMPENYSE American. Learn more on AMPEs analyst rating history.

Ampe Ampio Pharmaceuticals Inc Stock Overview U S Nyse American Barron S